The result is not the decision.
Accurate infectious disease testing gets a clinician most of the way. The last step, choosing the right treatment from the result, is where outcomes, cost and resistance are decided. Join Dr. Ari Frenkel and Molecular Testing Labs for a candid hour on what happens in that gap and what closes it.
Presented by Arkstone Medical Solutions with Molecular Testing Labs, an Arkstone Qualified Lab.
Getting the prescribing decision right pays back four ways.
Antimicrobial resistance is no longer a distant risk. It shapes every prescribing decision made today, often in settings with no infectious disease specialist within reach. This session looks at the full return on getting that decision right: better outcomes for the patient, lower cost of care, lower clinical risk and less resistance downstream.
The pressure at the point of prescribing
Why antimicrobial resistance matters now, what clinicians are up against when a result lands and why expert infectious disease guidance is missing from most care settings.
What accurate testing really detects
Inside Molecular Testing Labs' approach to infectious disease panels: how accuracy and quality are built in, what the panels identify that clinicians would otherwise underestimate and how testing reaches the settings that need it most.
Where testing meets the decision
A detailed result arrives and a clinician still has to decide what to do with it. What happens in that gap and what changes for the patient when interpretation arrives alongside the result.
Real cases, real outcomes
A provider experience walked through end to end: what was ordered, what came back, what was decided and what happened next. Plus what changed in practice for the lab and its clinicians once interpretation was part of the report.
Your questions, answered live
Submit questions in advance at registration or ask them live. Dr. Frenkel moderates an open Q&A with the panel in the final segment.
A conversation, not a slide deck.
This is an interview led session. Expect direct questions, practical answers and the parts of the story that do not usually make it into a presentation.
Dr. Ari Frenkel, MD MPH
Infectious disease physician and the clinical mind behind OneChoice, Arkstone's interpretive reporting and antimicrobial decision support. Dr. Frenkel hosts the Prescribe Responsibly podcast and works with laboratories and clinicians across the country on scaling infectious disease expertise to the point of care.
Kelly Chauvin, PharmD
Pharmacist and medical science liaison at Molecular Testing Labs, an Arkstone Qualified Lab. Kelly works at the intersection of laboratory science and clinical practice, helping providers understand what infectious disease panels detect and how to act on them responsibly.
Built for the people who make the call.
If you order infectious disease testing, interpret it or set the stewardship standards it is measured against, this hour is for you.
Save your seat.
Free to attend. Every registrant receives the recording, so sign up even if you cannot join live.
Save my seatThis session is for educational purposes only and does not constitute medical advice. The webinar will be recorded. By registering you agree to receive the recording and related follow up from Arkstone Medical Solutions and Molecular Testing Labs.